OpenAI and Retro Biosciences have partnered to develop GPT-4b micro, an AI model designed to enhance stem cell production efficiency. As reported by TechCrunch, this collaboration aims to extend human life expectancy by leveraging AI to redesign proteins crucial for cellular reprogramming.